Test,Reference
Sponsors
Sandoz (Thailand) Limited, T.O. Chemicals (1979) Ltd., SciGen Pte. Ltd., Sun Pharmaceutical Industries Ltd.
Conditions
Healthy
Bioequivalence study
Edoxaban
PharmacokineticsHealthy
Bioequivalence study
Dapagliflozin Pharmacokinetics
Metformin PharmacokineticsHealthy
Bioequivalence study
Rivaroxaban PharmacokineticsHealthy
Bioequivalence study
Vildagliptin Pharmacokinetics
Metformin Pharmacokinetics
Phase 1
A Bioequivalence Study of Two Formulations of Edoxaban 60 mg Film-coated Tablets in Healthy Thai Subjects under Fasting Conditions
Active, not recruitingTCTR20240325004
Start: 2024-06-10Target: 52Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Rivaroxaban 20-mg Tablets, RELVAXA 20 and Xarelto 20 mg, in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20240813002
Start: 2024-09-18Target: 28Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Vildagliptin 50 mg and Metformin Hydrochloride 1000 mg in Healthy Thai Subjects under Fed Conditions
TCTR20240908005
Start: 2024-12-08Target: 48Updated: 2026-08-03
A Bioequivalence Study of Two Fixed-dose Combination of 10 mg Dapagliflozin and 1000 mg Metformin Hydrochloride Extended Release Tablets, xigduo XR 10 mg/1000 mg and Dapagliflozin and Metformin HCl Extended Release Tablets 10 mg/1000 mg, in Healthy Thai Subjects under Fasting Conditions
Active, not recruitingTCTR20250228004
Start: 2025-09-29Target: 60Updated: 2026-08-03
A Bioequivalence Study of Two Fixed-dose Combination of 10 mg Dapagliflozin and 1000 mg Metformin Hydrochloride Extended Release Tablets, xigduo XR 10 mg/1000 mg and Dapagliflozin and Metformin HCl Extended Release Tablets 10 mg/1000 mg, in Healthy Thai Subjects under Fed Conditions
Active, not recruitingTCTR20250302010
Start: 2025-11-25Target: 60Updated: 2026-08-03